Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Rosuvastatin

Aliases
5 mg rosuvastatin calcium with a Web App (combination product), Crestor, Crestor 5 mg, group B, rosuvastatin (8 other aliases)
Name
Rosuvastatin
FDA Approved
Yes

98 clinical trials

49 organizations

1 drug

76 indications

5 documents

Indication
Hypercholesterolemia
Indication
Healthy Participants
Indication
Cirrhosis
Indication
Healthy Control Participants
Indication
lipid metabolism disorder
Indication
Drug-drug interactions
Indication
Healthy
Indication
Sickle Cell Disease
Indication
Adult Health
Indication
Type 2 Diabetes Mellitus
Indication
Diabetes Mellitus
Indication
Type 2
Indication
Obesity
Indication
Dyslipidemia Associated With Type II Diabetes Mellitus
Indication
Advanced Solid Tumor
Indication
Solid Tumor
Indication
Adult
Indication
Advanced Non-small Cell Lung Cancer
Indication
EGFR mutation
Indication
HER2 Mutation
Indication
Atherosclerotic Cardiovascular Disease
Indication
Metastatic Solid Tumor
Indication
Healthy Subjects
Indication
pharmacokinetics
Indication
Cancer
Indication
Hyperlipidemia
Indication
Hypertension
Indication
Malaria
Indication
Colorectal Cancer
Indication
COVID-19
Indication
Healthy Male Participants
Indication
Vasomotor Symptoms
Indication
Primary Sclerosing Cholangitis
Indication
Inflammatory Bowel Disease
Indication
Cardiovascular Disease
Indication
Coronary Artery Disease
Indication
Peripheral Artery Disease
Indication
Polyvascular Disease
Indication
Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
Indication
Clonal Cytopenia of Undetermined Significance
Indication
Myelodysplastic Syndromes
Indication
Atypical Endometrial Hyperplasia
Indication
Endometrial Carcinoma
Indication
stroke
Indication
Dyslipidemia
Indication
Primary Prevention
Indication
Chemotherapy-induced Cardiotoxicity
Indication
Breast Cancer
Indication
Intracerebral hemorrhage
Indication
Cholesterol
Indication
Liver
Indication
Cirrhosis due to Hepatitis B
Indication
Cirrhosis Advanced
Indication
Alcoholic liver disease
Indication
Biliary
Indication
Hepatitis C-related cirrhosis
Indication
Myocardial infarction with Q wave
Indication
Atherosclerosis
Indication
Coronary
Indication
Cardiovascular Disorder
Indication
Prostate Cancer
Indication
Castration-Resistant
Indication
ST Elevation Myocardial Infarction
Indication
Psoriatic Arthritis
Indication
Dual Antiplatelet Therapy
Indication
Statin
Indication
Venous Thromboembolism
Indication
Venous thromboembolism
Indication
Post-thrombotic syndrome
Indication
ST-segment Elevation Myocardial Infarction
Indication
Non-alcoholic Steatohepatitis
Indication
Interaction Drug Food
Indication
Chemotherapy-Induced Systolic Dysfunction
Indication
Familial Hypercholesterolemia
Indication
Lipid Disorder
Drug
Rosuvastatin
Indication
ulcerative colitis
Clinical trial
A Phase III, 6-Month Self-selection and Actual Use Study for Rx-to-OTC Switch of Rosuvastatin 5 mg Once-daily in Combination With a Web App
Status: Completed, Estimated PCD: 2023-03-01
Clinical trial
An Open-Label, Single-Sequence Crossover, Drug-Drug Interaction Study to Assess the Effect of Steady-State BMS-986322 on the Pharmacokinetics of Rosuvastatin (Part 1), the Pharmacokinetics and Pharmacodynamics of Metformin (Part 2) and the Pharmacokinetics of Methotrexate (Part 3) in Healthy Participants
Status: Completed, Estimated PCD: 2023-12-13
Clinical trial
Transporter Profiling Study for P-glycoprotein 1 (P-gp), Organic Anion Transporter 1 (OAT1), Organic Anion Transporter 3 (OAT3), Organic Cation Transporter 2 (OCT2), Multidrug and Toxin Extrusion Protein 1 (MATE1), Multidrug and Toxin Extrusion Protein 2-K (MATE2-K), Organic Anion Transporting Polypeptide 1B1 (OATP1B1), Organic Anion Transporting Polypeptide 1B3 (OATP1B3) and Breast Cancer Resistance Protein (BCRP) in Healthy Subjects and in Patients With Stage 4 (F4) Liver Fibrosis / Cirrhosis.
Status: Recruiting, Estimated PCD: 2025-01-14
Clinical trial
A Phase 1 Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Status: Active (not recruiting), Estimated PCD: 2024-03-31
Clinical trial
A Phase I, Randomized, Single-Blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 Following Single and Multiple Ascending Dose Administration to Healthy Subjects With or Without Elevated LDL-C Levels
Status: Recruiting, Estimated PCD: 2024-03-08
Clinical trial
A Open-Label, Two-sequence Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid in Healthy Participants
Status: Completed, Estimated PCD: 2023-11-20
Clinical trial
A Fixed Sequence, Open-label Study to Assess the Effect of Multiple Doses of AZD5462 on the Pharmacokinetics of Oral Midazolam (CYP3A4 Probe), Rosuvastatin (OATP1B1/3, BCRP Probe), and Digoxin (P-gp Probe) in Healthy Participants
Status: Completed, Estimated PCD: 2022-09-12
Clinical trial
An Open-Label, 2-Part Study to Investigate the Effect of Lasmiditan on the Pharmacokinetics of Dabigatran and Rosuvastatin in Healthy Volunteers
Status: Completed, Estimated PCD: 2021-07-06
Clinical trial
A Phase 1, Open-Label, Two-Part, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Effect of Voxelotor on the Pharmacokinetics of Selected CYP and Transporter Probe Substrates in Healthy Participants
Status: Completed, Estimated PCD: 2023-10-04
Clinical trial
A Study to Evaluate the Effect of Daily Doses of Obicetrapib Tablets on the Pharmacokinetics of Atorvastatin Calcium Tablets or Rosuvastatin Calcium Tablets in Healthy Adult Subjects
Status: Completed, Estimated PCD: 2023-12-02
Clinical trial
402-C-1104
Status: Completed, Estimated PCD: 2012-07-31
Clinical trial
A Phase 1, Open Label, Fixed Sequence Study to Evaluate the Effect of ECC5004 on the Single Dose Pharmacokinetics of Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Status: Recruiting, Estimated PCD: 2024-04-19
Clinical trial
A Single-Center, Open-Label Study to Evaluate the Effect of XW003 Injection on the Pharmacokinetics of Metformin, Warfarin, Rosuvastatin or Digoxin in Healthy Subjects
Status: Recruiting, Estimated PCD: 2024-01-08
Clinical trial
A Phase 1, Open-Label, 4-Part, Drug-Drug Interaction Study With Omaveloxolone in Healthy Subjects
Status: Completed, Estimated PCD: 2019-08-18
Clinical trial
Evaluation of the Effects of Exendin-4 Fc Fusion Protein (JY09) Injection on the Pharmacokinetic Profiles of Metformin Hydrochloride Tablets, Rosuvastatin Calcium Tablets, and Digoxin Tablets and on the QT Interval in Overweight Chinese Subjects
Status: Active (not recruiting), Estimated PCD: 2024-04-07
Clinical trial
Relative Bioavailability of Rosuvastatin (Part 1) and Dabigatran (Part 2) Given Alone and Together With BI 1323495 in Healthy Male Subjects (Open, Single-dose, Randomised, Two-period Crossover Design in Each Trial Part)
Status: Completed, Estimated PCD: 2020-09-23
Clinical trial
Phase 1, Open-Label, Drug Interaction Study to Investigate the Effect of Single Dose Selpercatinib on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Status: Completed, Estimated PCD: 2023-10-31
Clinical trial
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
Status: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
A Phase 1, Single-Center, Open-Label, Fixed-Sequence Study to Evaluate the Effect of DC-806 on the Single Dose Pharmacokinetics of CYP450 Enzyme and Transporter Substrates in Healthy Participants
Status: Completed, Estimated PCD: 2023-11-28
Clinical trial
A Two-cohort, Two-part, Phase 1, Multicenter, Open-label, Fixed-sequence, Drug-Drug Interaction and QTc Assessments of Sitravatinib Followed by Combination Treatment With Nivolumab in Patients With Advanced Solid Malignancies
Status: Completed, Estimated PCD: 2022-12-22
Clinical trial
A Drug-Drug Interaction Study to Assess the Effect of Orforglipron on the Pharmacokinetics of Digoxin, Simvastatin, Rosuvastatin, Acetaminophen, and Midazolam in Healthy Overweight and Obese Participants
Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
a Single-center, Non-randomized, Open-label, Self-controlled Phase 1 Clinical Study to Evaluate Drug-drug Interactions of JMKX001899 Tablets in Healthy Subjects
Status: Not yet recruiting, Estimated PCD: 2024-05-31
Clinical trial
A Phase 1, Open Label, Fixed Sequence, Crossover Study to Investigate the Effect of BAY 2927088 on the Pharmacokinetics of Dabigatran Etexilate or Rosuvastatin in Healthy Participants
Status: Recruiting, Estimated PCD: 2024-05-23
Clinical trial
A Three-Part Phase 1 Study to Evaluate the Potential Drug-Drug Interactions Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel-Ethinyl Estradiol-Containing Oral Contraceptives, and Carbamazepine in Healthy Adult Participants
Status: Recruiting, Estimated PCD: 2024-03-22
Clinical trial
A Phase I/IIa Trial to Evaluate the Safety, Tolerability, PK, and Preliminary Efficacy of Single and Multiple Ascending Doses of YN001 in Healthy Subjects and Multiple Ascending Doses of YN001 in Patient With Coronary Atherosclerosis
Status: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Escalating Oral Doses of PF-06954522 in Adult Participants With Type 2 Diabetes Mellitus
Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Open-Label, Two-sequence Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of Leritrelvir With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin in Healthy Participants
Status: Completed, Estimated PCD: 2023-11-01
Clinical trial
A Phase 1, Open-Label, Fixed-Sequence Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors Harboring ROS1 or NTRK1-3 Rearrangements
Status: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
A Phase 1 Study to Evaluate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants
Status: Completed, Estimated PCD: 2024-02-05
Clinical trial
A Single-center, Open-label, One-sequence, Two-treatment Study to Investigate the Effect of ACT-132577 at Steady State on the Pharmacokinetics of Rosuvastatin in Healthy Male Subjects
Status: Completed, Estimated PCD: 2017-09-18
Clinical trial
A Phase 1 Study to Evaluate the Potential Drug Interaction Between ALXN2040 and Rosuvastatin in Healthy Adult Participants
Status: Completed, Estimated PCD: 2023-03-23
Clinical trial
A PHASE 1, OPEN -LABEL, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF TWO STEADY STATE DOSE LEVELS OF PF-06882961 ON THE PHARMACOKINETICS OF SINGLE ORAL DOSES OF ROSUVASTATIN AND MIDAZOLAM IN OTHERWISE HEALTHY ADULT PARTICIPANTS WITH OBESITY
Status: Completed, Estimated PCD: 2021-05-13
Clinical trial
Investigation of Mutual Pharmacokinetic Interactions of Digoxin, Furosemide, Metformin, and Rosuvastatin Given All Together as a Probe Cocktail for Key Drug Transporters (an Open-label, Randomised, Single-dose, Five-way Crossover Study)
Status: Completed, Estimated PCD: 2016-11-11
Clinical trial
A Phase I, Open-label, Fixed-sequence, Two-period, Crossover, Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of Ganaplacide and Lumefantrine Combination on the Pharmacokinetics of Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir in Healthy Participants
Status: Completed, Estimated PCD: 2022-10-17
Clinical trial
A PHASE 1, RANDOMIZED, FIXED SEQUENCE, MULTIPLE-DOSE, OPEN-LABEL STUDY TO ESTIMATE THE EFFECT OF NIRMATRELVIR (PF-07321332)/RITONAVIR ON ROSUVASTATIN PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS
Status: Completed, Estimated PCD: 2023-08-10
Clinical trial
A Phase 1, Parallel-group, 3-part, 2-period, Fixed-sequence, Crossover, Open-label, Nonrandomized, Drug-drug Interaction Study to Assess the Pharmacokinetics of CC-92480 (BMS-986348) After Coadministration With Rifampin and Itraconazole, and Pharmacokinetics of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants
Status: Completed, Estimated PCD: 2022-11-12
Clinical trial
A Phase 1, Open-label, Drug-drug-interaction Study to Determine the Effect of Rucaparib on the Pharmacokinetics of Oral Rosuvastatin (Arm A) and Oral Contraceptives (Ethinylestradiol and Levonorgestrel) (Arm B) in Patients With Advanced Solid Tumors
Status: Completed, Estimated PCD: 2019-12-06
Clinical trial
A Four-part, Single-center, Open-label, Phase I Clinical Study to Evaluate the Drug-drug Interactions (DDIs) Between GP681 and Rosuvastatin/Digoxin/Itraconazole/Oseltamivir in Chinese Healthy Volunteers
Status: Completed, Estimated PCD: 2023-09-11
Clinical trial
A Non-interventional, Multi Center, Prospective Observational Study to Evaluate the Effect of Improving Systolic Blood Pressure and Low-density Lipoprotein Cholesterol Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab. in Patients With Essential Hypertension and Dyslipidemia.
Status: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
Relative Bioavailability of a Single Oral Dose of Digoxin, Furosemide, Metformin, and Rosuvastatin Given Alone and All Together as a Cocktail, and Investigation of the Effect of Increased Doses of Metformin or Furosemide on Relative Bioavailability of the Other Cocktail Compounds in Healthy Male Subjects
Status: Completed, Estimated PCD: 2015-01-01
Clinical trial
AN INTERVENTIONAL, PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, 2-PERIOD STUDY TO EVALUATE THE EFFECT OF A SINGLE ORAL DOSE OF ARV-471 (PF-07850327) ON THE PHARMACOKINETICS OF ROSUVASTATIN IN HEALTHY PARTICIPANTS
Status: Completed, Estimated PCD: 2023-03-06
Clinical trial
The Effect of Imlunestrant on CYP2C8, CYP2C19, CYP2D6, P-gp, and BCRP Activity and the Effect of P-gp Inhibition on Imlunestrant Pharmacokinetics in Healthy Women of Non-childbearing Potential
Status: Completed, Estimated PCD: 2022-11-02
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study Followed by an Open Label Treatment Period to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Status: Completed, Estimated PCD: 2021-01-14
Clinical trial
A PHASE 1 STUDY TO EVALUATE THE EFFECTS OF MULTIPLE DOSES OF LY3537982 ON THE SINGLE-DOSE PHARMACOKINETICS OF MIDAZOLAM, DIGOXIN, AND ROSUVASTATIN IN HEALTHY ADULT SUBJECTS
Status: Not yet recruiting, Estimated PCD: 2024-01-31
Clinical trial
A Phase 1, Open-label, 2-part, 2-period Fixed-sequence Study to Evaluate the Effect of Fruquintinib on the Pharmacokinetics of Dabigatran Etexilate (A P-GP Substrate) and Rosuvastatin (A BCRP Substrate) in Healthy Subjects
Status: Completed, Estimated PCD: 2022-04-22
Clinical trial
A Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 on LDL-C in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia
Status: Completed, Estimated PCD: 2013-11-12
Clinical trial
A NON-RANDOMIZED, MULTIPLE-DOSE, OPEN-LABEL, SINGLE SEQUENCE STUDY TO EVALUATE THE EFFECT OF CONCOMITANT ADMINISTRATION OF EDP-235 ON THE PHARMACOKINETICS AND SAFETY OF MIDAZOLAM, CAFFEINE, AND ROSUVASTATIN IN HEALTHY PARTICIPANTS
Status: Completed, Estimated PCD: 2022-11-04
Clinical trial
An Open-label, 2-Period, 2-Sequence Cross-over Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Status: Completed, Estimated PCD: 2023-05-15
Clinical trial
Open-label, One-sequence Crossover Study to Determine the Effects of Multiple Doses of Elinzanetant on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Status: Completed, Estimated PCD: 2021-07-23
Clinical trial
A Phase I, Fixed-sequence, Open-label Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Substrates of Human Transporters Digoxin (P-gp), Rosuvastatin (OATP1B1/3), Metformin (OCT2, MATE1/2K), and Furosemide (OAT1/3) in Healthy Male Subjects
Status: Completed, Estimated PCD: 2023-06-24
Clinical trial
A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE STUDY TO ESTIMATE THE EFFECT OF PF-07081532 ADMINISTRATION ON THE SINGLE-DOSE PHARMACOKINETICS OF DABIGATRAN AND ROSUVASTATIN IN OVERWEIGHT OR OBESE ADULT PARTICIPANTS
Status: Terminated, Estimated PCD: 2023-09-11
Clinical trial
A Single-center, Open-label, Three-period, Fixed-sequence Design Study to Investigate the Effect of Daridorexant on the Pharmacokinetics of Dabigatran and Rosuvastatin in Healthy Male Subjects
Status: Completed, Estimated PCD: 2022-09-17
Clinical trial
The Effect of Different Doses of Metformin or Furosemide on Rosuvastatin Pharmacokinetics Following Oral Administration in Healthy Male Subjects (an Open-label, Randomised, Single-dose, Six-way Crossover Study)
Status: Completed, Estimated PCD: 2015-12-09
Clinical trial
The Effect of Potent Inhibitors of Drug Transporters (Verapamil, Rifampin, Cimetidine, Probenecid) on Pharmacokinetics of a Transporter Probe Drug Cocktail Consisting of Digoxin, Furosemide, Metformin and Rosuvastatin (an Open-label, Randomised, Crossover Trial in Three Parts)
Status: Completed, Estimated PCD: 2018-05-02
Clinical trial
A Phase I, Open-label, Fixed Sequence Crossover Study to Investigate the Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin, a Breast Cancer Resistance Protein Substrate, in Healthy Subjects
Status: Completed, Estimated PCD: 2021-10-10
Clinical trial
The Effect of Statin Therapy on Bile Acid Physiology and the Microbiome in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Status: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction
Status: Terminated, Estimated PCD: 2022-01-27
Clinical trial
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
Status: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
Status: Not yet recruiting, Estimated PCD: 2026-05-06
Clinical trial
The Effect of Usual Dose Rosuvastatin Plue Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque: A Randomized Controlled Trial
Status: Active (not recruiting), Estimated PCD: 2027-01-28
Clinical trial
Effect of Early Initiation of Evolocumab and Combination Lipid-lowering Agent on Lipid Profiles Changes in Patients With Acute Coronary Syndrome Undergoing percuTAneous coronaRy Intervention: a Prospective, Randomized Controlled Trial
Status: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Pilot Study of Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
Status: Recruiting, Estimated PCD: 2027-05-31
Clinical trial
Using OFR Software to Observe the Effects of Inclisiran Combined With Statins on the Morphology and Vascular Function of Coronary Vulnerable Plaques
Status: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia
Status: Completed, Estimated PCD: 2022-06-20
Clinical trial
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Status: Recruiting, Estimated PCD: 2025-08-31
Clinical trial
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke, a Randomized Controlled Single-blinded Trial
Status: Recruiting, Estimated PCD: 2025-04-10
Clinical trial
Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia
Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention : A Prospective, Multicenter, Randomized, Open-label Trial
Status: Recruiting, Estimated PCD: 2029-02-28
Clinical trial
Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Status: Completed, Estimated PCD: 2023-09-15
Clinical trial
Statins and 90-day Functional Efficiency and Survival in Patients With Spontaneous Intracerebral Hemorrhage
Status: Completed, Estimated PCD: 2020-12-31
Clinical trial
A Multicenter, Randomized, Double-Blind, Titration Study to Evaluate the Efficacy and Safety of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia at Risk for Coronary Heart Disease
Status: Completed, Estimated PCD: 2010-05-01
Clinical trial
Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study
Status: Recruiting, Estimated PCD: 2026-11-01
Clinical trial
Effects of Pediatric Liver Adiposity on Statin Disposition and Response
Status: Recruiting, Estimated PCD: 2025-01-30
Clinical trial
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
Status: Completed, Estimated PCD: 2023-08-01
Clinical trial
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein
Status: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Effects of High-dose StAtin Versus Low-dose Statin Plus Ezetimibe on Statin-Associated Muscle Symptoms & on Reaching Target LDL-C Levels Among Elderly Patients With Atherosclerotic Cardiovascular Disease
Status: Completed, Estimated PCD: 2023-05-14
Clinical trial
INvestigation of the Gut microbiomE and STatin Response (INGEST)
Status: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A Randomized, Double-Blind, Active-Controlled Study of Patients With Cardiovascular Disease and Diabetes Mellitus Not Adequately Controlled With Simvastatin or Atorvastatin: Comparison of Switching to Combination Tablet Ezetimibe/Simvastatin Versus Switching to Rosuvastatin or Doubling the Statin Dose
Status: Completed, Estimated PCD: 2011-03-01
Clinical trial
Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Subjects With Castration-Resistant Prostate Cancer
Status: Recruiting, Estimated PCD: 2016-11-01
Clinical trial
A Phase III, Randomized, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of MK-0653H in Japanese Patients With Hypercholesterolemia.
Status: Completed, Estimated PCD: 2017-01-18
Clinical trial
Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (EVALUATE-STEMI Trial): a Prospective, Multicenter, Open-label, Adjudicator-blinded, Randomized Clinical Trial
Status: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Effects of Tight-control Strategy With and Without Rosuvastatin on Progression of Subclinical Carotid and Coronary Atherosclerosis in Psoriatic Arthritis- a Randomized Controlled Study
Status: Withdrawn, Estimated PCD: 2022-12-31
Clinical trial
Early Intensive Medical Therapy for the Prevention of Early Neurological Deterioration in Branch Atheromatous Disease
Status: Recruiting, Estimated PCD: 2024-02-28
Clinical trial
An Open-Label Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics When Administered Orally to Healthy Adult Participants
Status: Recruiting, Estimated PCD: 2024-08-10
Clinical trial
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
Supplements, Placebo, or Rosuvastatin Study
Status: Completed, Estimated PCD: 2022-07-19
Clinical trial
Comparative Study Between the Effects of High Doses Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction
Status: Completed, Estimated PCD: 2023-03-01
Clinical trial
Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Rosuvastatin Versus Coenzyme Q10 on Nonalcoholic Steatohepatitis
Status: Not yet recruiting, Estimated PCD: 2024-02-01
Clinical trial
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach
Status: Completed, Estimated PCD: 2018-11-30
Clinical trial
Effects of Rosuvastatin on Markers of Atherosclerosis in Diabetic Patients Treated With Glimepiride/Metformin Combination
Status: Completed, Estimated PCD: 2021-01-19
Clinical trial
Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy
Status: Not yet recruiting, Estimated PCD: 2025-05-01
Clinical trial
A Phase III, Open-label, Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Patients With Hypercholesterolemia Who Have Inadequate LDL-C Control on Ezetimibe or Rosuvastatin Monotherapy
Status: Completed, Estimated PCD: 2017-12-11
Clinical trial
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
Status: Completed, Estimated PCD: 2023-06-01
Clinical trial
A MC, DB, Rand, Study to Evaluate Efficacy, Safety and Tolerability of Eze/Simva 10/40 mg, Atorva 40 mg, Rosuva 10 mg in Achieving LDL-C <2 mmol/l in Pts With CVD...on Simva 40 mg With LDL-C ³2 mmol/l
Status: Completed, Estimated PCD: 2008-06-01
Clinical trial
Ezetimibe Phase IV Clinical Study in Patients With Hypercholesterolemia
Status: Completed, Estimated PCD: 2010-05-01
Clinical trial
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA, a Randomized Controlled Single-blinded Trial
Status: Recruiting, Estimated PCD: 2025-04-10
Clinical trial
A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Assess the LDL-C Lowering of Switching to a Combo Tab Ezetimibe/Simvastatin (10 mg/20 mg) Compared to Rosuvastatin 10 mg in Patients With Primary High Cholesterol and High Cardiovascular Risk Not Controlled With a Prior Statin Treatment
Status: Completed, Estimated PCD: 2008-03-01
Clinical trial
Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis
Status: Recruiting, Estimated PCD: 2025-11-22
Document
DailyMed Label: Rosuvastatin Calcium
Organization
Proficient Rx LP
Document
DailyMed Label: Rosuvastatin
Organization
A-S Medication Solutions
Organization
Aurobindo Pharma Limited
Organization
Preferred Pharmaceuticals Inc.,
Organization
Zhejiang Yongtai Pharmaceutical Co., Ltd.
Organization
Preferred Pharmaceuticals Inc.
Organization
Northwind Pharmaceuticals
Organization
Accord Healthcare Inc.
Organization
American Health Packaging
Organization
DIRECT RX
Organization
Quality Care Products, LLC
Organization
Amneal Pharmaceuticals NY LLC
Organization
Solco Healthcare LLC
Organization
Direct_Rx
Organization
Zydus Lifesciences Limited
Organization
NuCare Pharmaceuticals,Inc.
Organization
Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Organization
bryant ranch prepack
Organization
REMEDYREPACK INC.
Organization
UMEDICA LABORATORIES PRIVATE LIMITED
Organization
NorthStar RxLLC
Organization
EMC PHARMA, LLC
Organization
Aphena Pharma Solutions - Tennessee, LLC
Organization
Golden State Medical Supply, Inc.
Organization
Preferred Pharmaceuticals, Inc.
Organization
Northwind Pharmaceuticals, LLC
Organization
Aphena Pharma Solutions - Tennessee, LLC
Organization
Glenmark Pharmaceutials Inc., USA
Organization
Quallent Pharmaceuticals Health LLC
Document
DailyMed Label: Rosuvastatin Calcium
Organization
Torrent Pharmaceuticals Limited
Organization
Tris Pharma Inc
Organization
Ascend Laboratories, LLC
Organization
Novadoz Pharmaceuticals LLC
Organization
Aphena Pharma Solutions - Tennessee, LLC
Document
DailyMed Label: CRESTOR
Organization
AstraZeneca Pharmaceuticals LP
Organization
PuraCap Laboratories LLC dba Blu Pharmaceuticals
Organization
Cardinal Health 107, LLC
Document
DailyMed Label: EZALLOR SPRINKLE
Organization
Sun Pharmaceutical Industries, Inc.
Organization
Major Pharmaceuticals
Organization
AvPAK
Organization
MSN LABORATORIES PRIVATE LIMITED
Organization
Westminster Pharmaceuticals, LLC
Organization
Shandong New Time Pharmaceutical Co., Ltd.
Organization
Cadila Pharmaceuticals Limited
Organization
Rising Pharma Holdings, Inc.
Organization
H.J. Harkins Company, Inc.
Organization
Biocon Pharma Inc.
Organization
ScieGen Pharmaceuticals, Inc.
Organization
Preferred Pharmaceuticals Inc. USA